Immucor Agrees to TPG Deal with Go-Shop
Listed, Georgia-based blood transfusion systems developer Immucor agreed to a deal just south of $2 billion with private equity firm TPG Capital, and earned itself a go-shop clause until August 15, 2011 to get itself a better deal. Goldman, Sachs & Co. acted as financial advisor to Immucor, Inc. and King & Spalding LLP acted as the Company's legal advisor. Ropes & Gray LLP acted as legal advisor to TPG Capital. Citi and J.P. Morgan Securities LLC acted as financial advisors and provided fully committed financing to TPG Capital.
5 July 2011•5 mins read
